Luxbright (LXB) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
20 Aug, 2026Executive summary
Focus shifted to areas with highest long-term value potential, emphasizing advanced X-ray technology and customer-driven operations.
Active dialogues with customers and partners to commercialize technology and production platform.
Organization adapted to current business volume, aiming for stepwise growth through OEM deals and development assignments.
Financial highlights
Net sales for Jan–Jun 2026 were 3,470 KSEK, down 35% year-over-year due to delayed deliveries from component shortages.
Operating result was -12,005 KSEK (vs. -9,817 KSEK), with a negative margin; net result after tax was -12,235 KSEK (vs. -9,972 KSEK).
Cash flow from operations was -12,298 KSEK; total cash flow for the period was -4,933 KSEK.
Equity at period end was 23,408 KSEK; cash and bank balances were 362 KSEK.
Outlook and guidance
No quantified forecast for 2026, but management sees strong positioning for continued commercialization.
Focus remains on OEM development, technical assignments, and leveraging core X-ray technology.
Latest events from Luxbright
- 40% sales growth achieved, but losses deepened; new financing required in 2026.LXB
H2 2025 - Revenue up 61% to 5.4 MSEK; rights issue raised 14 MSEK for innovation and growth.LXB
H1 2025 - Net sales exceeded 3 MSEK, losses narrowed, and liquidity improved via new share issues.LXB
H1 2024 - 2024 saw record sales, narrowed losses, and major orders, setting up strong growth for 2025.LXB
H2 2024